Gevo, Inc. (GEVO) Stock Forecast Nov. 6, 2026
Analysis updated on Nov. 6, 2026 (UTC) · Alpha · vs marketSwitch to Total · Nasdaq
Gevo, Inc. (GEVO) stock forecast summary
Our AI scores Gevo, Inc. every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
Gevo, Inc. is a small-cap company with a market capitalization of $344M. It ranks number 10 by market capitalization among the 23 Industrial Organic Chemicals issuers in our coverage with a current forecast.
For GEVO, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 11.0%, measured on 357 forecast dates between 2022-08-19 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is -1.0%, measured on 400 forecast dates between 2022-08-19 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +3.1%, buy ≥ +1.5%, sell < -0.5%, strong sell < -1.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-11-06 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, GEVO included.
GEVO price chart and AI forecast
How GEVO ranks among 5150 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Gevo, Inc. (GEVO) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Industrial Organic Chemicals peers listed below that report each metric.
Valuation & Market
| Metric | GEVO | Rank |
|---|---|---|
| Market Cap | $344M | 10/23 |
| P/B Ratio | 1.26x | 9/13 |
| EPS | $-0.90 | – |
| Book Value/Share | $1.10 | – |
| Revenue/Share | $0.72 | – |
| FCF/Share | $-0.23 | – |
Profitability & Margins
| Metric | GEVO | Rank |
|---|---|---|
| ROE | -77.9% | 9/11 |
| ROA | -43.4% | 11/15 |
| ROIC | -40.3% | 16/17 |
| Gross Margin | 51.2% | 5/18 |
| Operating Margin | -102.8% | 15/18 |
| Net Margin | -119.9% | 10/13 |
| EBT Margin | -100.0% | 16/19 |
| Tax Rate | -0.0% | – |
Financial Health
| Metric | GEVO | Rank |
|---|---|---|
| Current Ratio | 2.70x | 9/21 |
| Quick Ratio | 2.19x | 7/15 |
| D/E Ratio | 0.77x | 9/15 |
| Financial Leverage | 1.80x | 11/16 |
| Interest Coverage | -33.8x | 17/18 |
| Working Capital | $64M | 11/20 |
Cash Flow
| Metric | GEVO | Rank |
|---|---|---|
| Operating Cash Flow | -$16M | 18/20 |
| Free Cash Flow | -$57M | 15/15 |
| Capital Spending | -$40M | 8/15 |
| FCF/Sales | -31.9% | 13/15 |
| CapEx/Sales | 22.8% | 1/15 |
Operational Efficiency
| Metric | GEVO | Rank |
|---|---|---|
| Asset Turnover | 0.36x | 14/17 |
| Receivables Turnover | 14.8x | 7/13 |
| Inventory Turnover | 4.5x | 10/14 |
| Fixed Assets Turnover | 0.8x | 15/16 |
| Days Sales Outstanding | 25 days | 7/13 |
| Days Inventory | 81 days | 5/14 |
| Payables Period | 33 days | 8/12 |
| Cash Conversion Cycle | 73 days | 4/8 |
Income Statement
| Metric | GEVO | Rank |
|---|---|---|
| Total Revenue | $178M | 11/16 |
| Operating Income | -$182M | 17/18 |
| Net Income | -$213M | 15/16 |
| R&D Expense | $4M | 5/10 |
| Cost of Goods Sold | $87M | 11/17 |
Dividend & Shareholder Information
| Metric | GEVO | Rank |
|---|---|---|
| Shares Outstanding | 247M | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $102M | 20.7% of assets |
| Cash & Short-term Investments | $58M | 11.9% of assets |
| Accounts Receivable | $12M | 2.4% of assets |
| Inventory | $19M | 3.9% of assets |
| Total Liabilities | $210M | 42.7% of assets |
| Short-term Debt | $30M | 6.1% of assets |
GEVO quarterly financials and insider trading
Gevo, Inc. (GEVO) industry peers
Companies classified under the same SEC industry code as Gevo, Inc. (Industrial Organic Chemicals): 24 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| GEVO Gevo, Inc. | $344M | |
| IFF International Flavors & Fragrances Inc | $21.08B | |
| LYB Lyondellbasell Industries N.V. | $19.63B | |
| WLK Westlake Corp | $8.47B | |
| MEOH Methanex Corp | $5.13B | |
| SXT Sensient Technologies Corp | $5.07B | |
| REX Rex American Resources Corp | $1.31B | |
| GPRE Green Plains Inc. | $927M | |
| WLKP Westlake Chemical Partners Lp | $752M | |
| BAK Braskem Sa | $434M | |
| ALTO Alto Ingredients, Inc. | $290M | |
| FF Futurefuel Corp. | $237M | |
| LODE Comstock Inc. | $148M | |
| CDXS Codexis, Inc. | $118M | |
| AMTX Aemetis, Inc | $117M | |
| LNZA Lanzatech Global, Inc. | $65M | |
| VGAS Verde Clean Fuels, Inc. | $44M | |
| SAFX Xcf Global, Inc. | $36M | |
| TOMZ Tomi Environmental Solutions, Inc. | $18M | |
| GWTI Greenway Technologies, Inc. & Subsidiaries | $10M | |
| CNEY Cn Energy Group. Inc. | $6M | |
| CLNV Clean Vision Corp | $6M | |
| QGAI Quantum Genesis Ai Corp. | $1M | |
| SUIC Suic Worldwide Holdings Ltd. | N/A |
Where GEVO sits on the market map
Gevo, Inc. (GEVO) stock news
Loading...
Gevo, Inc. (GEVO) stock forecast FAQ
What is the Gevo, Inc. (GEVO) stock forecast?
Our AI scores Gevo, Inc. every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
How accurate are Gevo, Inc. stock predictions?
For GEVO, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 11.0%, measured on 357 forecast dates between 2022-08-19 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is -1.0%, measured on 400 forecast dates between 2022-08-19 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Gevo, Inc. forecasts updated?
Gevo, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Nov. 6, 2026.
Which companies are Gevo, Inc.'s industry peers?
24 issuers in our coverage, GEVO included, share the SEC industry code Industrial Organic Chemicals. The largest are: International Flavors & Fragrances Inc (IFF), Lyondellbasell Industries N.V. (LYB), Westlake Corp (WLK), Methanex Corp (MEOH), Sensient Technologies Corp (SXT), Rex American Resources Corp (REX).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.